Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
02/2004
02/11/2004EP1388540A1 Acrylic esters and use thereof
02/11/2004EP1388535A1 Acylated arylcycloalkylamines and their use as pharmaceuticals
02/11/2004EP1388342A1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
02/11/2004EP1388341A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals
02/11/2004EP1387836A1 Phthalazine derivatives with angiogenesis inhibiting activity
02/11/2004EP1387831A1 Substituted arylketones
02/11/2004EP1387830A1 Novel 4-anilinoquinoline-3-carboxamides
02/11/2004EP1387679A1 Sulfonamides
02/11/2004EP1299356B1 Novel compounds
02/11/2004EP1006110B1 Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments
02/11/2004CN1474816A 4-amino-quinazolines
02/11/2004CN1474815A 4-amino-quinazolines
02/11/2004CN1474812A (Dihydro) isoquinoline derivatives as phosphodiesterase inhibitor
02/11/2004CN1474810A Substituted urea neuropeptide YY5 antagonists
02/11/2004CN1474803A Novel amide derivatives and medicinal use thereof
02/11/2004CN1474652A Substituted 4,5-dihydro-1,2,4-triazin -6-ones, 1,2,4-triazin-6-ones, and their use as fungicides and insecticides
02/11/2004CN1473826A Diaryl perfluoro cycolpenfene photochrmism compounds and its preparing method and use
02/11/2004CN1473814A Intemediate for preparing alkyl-dihalogeno phenyl substituted keto-enol
02/11/2004CN1137886C Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives
02/11/2004CN1137884C Indazole compounds and pharmaceutical compositions for inhibiting protein kinases and methods for their use
02/10/2004US6689806 Indolinone compounds as kinase inhibitors
02/10/2004US6689801 Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme
02/10/2004US6689798 Benzofuran derivatives
02/10/2004US6689797 Tetrahydropyridines, preparation method and pharmaceutical compositions containing same
02/10/2004US6689794 Aromatic sulfone hydroxamates and their use as protease inhibitors
02/10/2004US6689786 Sulfonylurea, sulfonylthiourea, sulfonylguanidine, sulfonylcyanoguanidine and acylsulfonamide derivatives; antithrombotics
02/10/2004US6689772 Antineoplastic agents; osteoporosis; polycystic kidney disease; antiviral agents
02/10/2004US6689770 Aryl sulfonyls as factor Xa inhibitors
02/10/2004US6689765 Viricides; antiinflammatory agents
02/10/2004US6689754 Heterocyclic glycyl β-alanine derivatives
02/10/2004CA2297134C A novel process for preparing intermediates or inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof
02/09/2004CA2436658A1 Polynuclear metal complexes as phosphorescence emitters in electroluminescent layer arrangements
02/05/2004WO2004011457A1 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof
02/05/2004WO2004011454A2 Quinolyl propyl piperidine derivatives, preparation method and intermediates and compositions containing same
02/05/2004WO2004011443A1 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
02/05/2004WO2004011438A1 Diaryl-substituted cyclic urea derivatives having an mch-modulatory effect
02/05/2004WO2004011436A1 Quinoline derivatives and their use as mycobacterial inhibitors
02/05/2004WO2004011418A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands
02/05/2004WO2004011410A1 Chemical compounds
02/05/2004WO2004011402A2 Novel arylimidazole derivatives, preparation and therapeutic uses thereof
02/05/2004WO2004010995A1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthristis
02/05/2004WO2003074475A3 Substituted aryl ketones
02/05/2004WO2002100886A8 Pyrrolidin-2-one derivatives as inhibitors of factor xa
02/05/2004US20040024399 Method for repairing damaged intervertebral discs
02/05/2004US20040024240 Process for preparing homophthalate derivatives
02/05/2004US20040024210 New compounds
02/05/2004US20040024208 Cyclic protein tyrosine kinase inhibitors
02/05/2004US20040024190 Viral polymerase inhibitors
02/05/2004US20040024066 E.g., N-(2-(Benzo(b)thiophen-5-ylmethanesulfonyl)-1-(3,4-dichloro- phenyl)- ethyl)-N-hydroxyformamide; gene expression inhibitors of s-CD23; autoimmune disease; antiallergens; matrix metalloprotease enzyme inhibitors
02/05/2004US20040024051 C10 heterosubstituted acetate taxanes
02/05/2004US20040024049 Cytotoxic agents containing novel potent taxanes and their therapeutic use
02/05/2004US20040024040 Inhibitors of GSK-3 and uses thereof
02/05/2004US20040024038 GABA enhancers in the treatment of diseases relating to reduced neurosteroid activity
02/05/2004US20040024024 Inhibiting matrix metalloproteinase and aggrecanase activity; for treatment of strokes and neurodegenerative diseases
02/05/2004US20040024023 1-Heterocyclylalkyl-3-sulfonyl-indole or -indazole derivatives as 5-hydroxytryptamine-6 ligands
02/05/2004US20040024010 3-methylidenyl-2-indolinone modulators of protein kinase
02/05/2004US20040024000 Dihydropyrimidine derivatives as cysteine protease inhibitors
02/05/2004US20040023993 Diagnosis and treatment of anxiety, Down Syndrome, sleep, cognitive and seizure disorders, depression, overdose with benzodiazepine drugs, and enhancement of memory and alertness; gamma-aminobutyric acid (gaba)
02/05/2004US20040023973 Novel compound having an excellent AMPA receptor inhibitory action and/or kainate inhibitory action. A compound represented by the following formula, a salt thereof or hydrates thereof.
02/05/2004US20040023963 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases
02/05/2004US20040023945 Cyclic amp-specific phosphodiesterase inhibitors
02/05/2004US20040023060 Structure including at least three planar moieties, which are linearly configured such that one planar moiety is located between two neighboring planar moieties and shares an atom with each of the moieties
02/05/2004DE10234875A1 4-Trifluormethylpyrazolyl substituierte Pyridine und Pyrimidine 4-substituted pyridines and pyrimidines Trifluormethylpyrazolyl
02/05/2004DE10148618A1 Substituierte N-(1,4,5,6-Tetrahydro-cyclopentapyrazol-3-yl)-Derivate, deren Herstellung und Verwendung als Arzneimittel Substituted N- (1,4,5,6-tetrahydro-cyclopentapyrazol-3-yl) derivatives, their preparation and use as medicaments
02/05/2004CA2494668A1 Chemical compounds
02/05/2004CA2493924A1 Diaryl-substituted cyclic urea derivatives having an mch-modulatory effect
02/05/2004CA2493751A1 Novel arylimidazole derivatives, preparation and therapeutic uses thereof
02/04/2004EP1386920A1 Benzimidazolone derivatives
02/04/2004EP1386913A1 Pyrrole derivative
02/04/2004EP1386912A1 Cyclic amidine derivative
02/04/2004EP1386279A2 Method for inhibiting metap2
02/04/2004EP1385848A2 Phtalazinones derivatives useful as pde4/7 inhibitors
02/04/2004EP1385845A1 N-aroyl cyclic amines
02/04/2004EP1385843A1 Arylindenopyridines with pde inhibiting activity
02/04/2004EP1385842A1 Heterocyclyloxy-, -thioxy- and -aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
02/04/2004EP1385841A1 Sulfonamides
02/04/2004EP1385840A1 Sulfonamides
02/04/2004EP1385839A1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
02/04/2004EP1385836A2 Aromatic sulfone hydroxamates and their use as protease inhibitors
02/04/2004EP1385832A2 Production of tertiary amines by reductive amination
02/04/2004EP1385825A1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
02/04/2004EP1385507A1 Sulfonamides
02/04/2004EP1385493A1 Substituted cyclohexan-1,4-diamine derivatives with constipating and peripheral analgesic properties
02/04/2004CN1473161A Pyrazole compounds as protein kinase inhibitors
02/04/2004CN1473156A Pyrimidine derivatives and their use as neuropeptide y receptor ligands
02/04/2004CN1473154A Phthalazinone derivatives
02/04/2004CN1137119C Substituted thineyl (amino) sulfonylureas
02/03/2004US6686478 Thienylsulphonylamino(thio)carbonyl compounds
02/03/2004US6686390 Compounds having antiinflamatory activity: process for their preparation and pharmaceutical compositions containing them
02/03/2004US6686378 Derivatives of 3-imino-1,2-dithioles, method for producing them and pharmaceutical compositions containing the same
02/03/2004US6686372 Selective β3 adrenergic agonists
02/03/2004US6686368 Inhibitors of factor Xa
02/03/2004US6686353 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
02/03/2004US6686318 Heterocyclically substituted aromatic amino compounds with a herbicidal effect
01/2004
01/29/2004WO2004009586A1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
01/29/2004WO2004009583A2 Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor
01/29/2004WO2004009578A2 Pentacyclic oxepines and derivatives thereof, process for their preparation and pharmaceutical compositions containing them
01/29/2004WO2004009563A1 5-aryltetrazole compounds, compositions thereof, and uses therefor
01/29/2004WO2004009558A2 Ureido substituted benzoic acid compounds, their use for nonsense suppression and the treatment of diseases caused by such mutations
01/29/2004WO2004009556A1 4-(substituted aryl)-5-hydroxyisoquinolinone derivative